Pfizer has named chief oncology officer Dr Chris Boshoff to the new role of chief of R&D, as the company faces down criticism of its recent efforts to develop and build its pipeline. He is ...
GlobalData on MSN2mon
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025He emphasised a priority reshuffling within the company’s clinical pipeline, now overseen by Dr. Chris Boshoff who was ...
So that's why we believe this data … will lead to [Lorbrena] becoming a standard" first-line treatment in this specific form of lung cancer, Chris Boshoff, Pfizer's chief oncology officer ...
At Pfizer, she will be an executive vice president and will report to Chris Boshoff, the company’s new chief scientific officer, who leads all research and development. Her job will include ...
Chris Boshoff, Pfizer’s chief oncology officer Its new chief oncology officer, Dr Chris Boshoff, said the focus will be on four main cancer types: breast cancer, genitourinary cancers including ...
At the recent earnings call, Pfizer’s (NYSE:PFE) chief scientific officer, Chris Boshoff, said that PFE remains on track to deliver a data update on the GLP-1 receptor agonist in Q1 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback